An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
Clinical trial NCT06608212 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06608212
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-09
- Primary completion
- 2025-03-31
- Enrollment
- 150000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.